Cargando…
Anticoagulation Management in Severe Coronavirus Disease 2019 Patients on Extracorporeal Membrane Oxygenation
OBJECTIVE: To explore special coagulation characteristics and anticoagulation management in extracorporeal membrane oxygenation (ECMO)–assisted patients with coronavirus disease 2019 (COVID-19). DESIGN: Single-center, retrospective observation of a series of patients. PARTICIPANTS: Laboratory-confir...
Autores principales: | Guo, Zhen, Sun, Lin, Li, Bailing, Tian, Rui, Zhang, Xiaolin, Zhang, Zhongwei, Clifford, Sean P., Liu, Yuan, Huang, Jiapeng, Li, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473345/ https://www.ncbi.nlm.nih.gov/pubmed/32994131 http://dx.doi.org/10.1053/j.jvca.2020.08.067 |
Ejemplares similares
-
Implementation and Outcomes of a Mobile Extracorporeal Membrane Oxygenation Program in the United States During the Coronavirus Disease 2019 Pandemic
por: Odish, Mazen F., et al.
Publicado: (2021) -
Anticoagulation on extracorporeal membrane oxygenation (ECMO)
por: Khilnani, Praveen
Publicado: (2017) -
Endogenous glycosaminoglycan anticoagulation in extracorporeal membrane oxygenation
por: MacLaren, Graeme, et al.
Publicado: (2014) -
Extracorporeal membrane oxygenation support in 2019 novel coronavirus disease: indications, timing, and implementation
por: Li, Min, et al.
Publicado: (2020) -
Extracorporeal membrane oxygenation support during the coronavirus disease 2019 pandemic: Outcomes and technical considerations
por: Saeed, Omar, et al.
Publicado: (2021)